{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Narcolepsy+Type+2", "query": { "condition": "Narcolepsy Type 2" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 19, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Narcolepsy+Type+2&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T08:10:12.673Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06179407", "title": "Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "MK-6552", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 9, "start_date": "2024-01-24", "completion_date": "2024-10-23", "has_results": true, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 5, "location_summary": "Colorado Springs, Colorado • Brandon, Florida • Atlanta, Georgia + 2 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Brandon", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Columbia", "state": "South Carolina" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06179407" }, { "nct_id": "NCT05709873", "title": "Narcolepsy Nightmare Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Narcolepsy", "Narcolepsy Type 1", "Narcolepsy With Cataplexy", "Narcolepsy Type 2", "Narcolepsy Without Cataplexy" ], "interventions": [ { "name": "Imagery rehearsal therapy", "type": "BEHAVIORAL" }, { "name": "Targeted dream control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2023-02-22", "completion_date": "2024-04-30", "has_results": false, "last_update_posted_date": "2024-06-12", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05709873" }, { "nct_id": "NCT04096560", "title": "A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 1 (NT1)", "Narcolepsy Type 2 (NT2)" ], "interventions": [ { "name": "TAK-994", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 97, "start_date": "2020-05-27", "completion_date": "2021-11-05", "has_results": true, "last_update_posted_date": "2024-10-29", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 36, "location_summary": "Alabaster, Alabama • Phoenix, Arizona • Bellflower, California + 31 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Bellflower", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04096560" }, { "nct_id": "NCT06358950", "title": "A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 1" ], "interventions": [ { "name": "ALKS 2680", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 92, "start_date": "2024-03-28", "completion_date": "2025-07-31", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 29, "location_summary": "Los Angeles, California • Redwood City, California • San Francisco, California + 24 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06358950" }, { "nct_id": "NCT06752668", "title": "A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 1", "Narcolepsy Type 2", "Idiopathic Hypersomnia" ], "interventions": [ { "name": "ORX750", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centessa Pharmaceuticals (UK) Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 248, "start_date": "2024-12-23", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 29, "location_summary": "Auburn, Alabama • Chandler, Arizona • Scottsdale, Arizona + 24 more", "locations": [ { "city": "Auburn", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06752668" }, { "nct_id": "NCT07493265", "title": "A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "E2086", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2026-03-26", "completion_date": "2027-03-01", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 17, "location_summary": "Santa Ana, California • Brandon, Florida • Medley, Florida + 12 more", "locations": [ { "city": "Santa Ana", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Medley", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07493265" }, { "nct_id": "NCT06767683", "title": "A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Narcolepsy Type 1", "Narcolepsy Type 2", "Idiopathic Hypersomnia" ], "interventions": [ { "name": "ALKS 2680, 4mg", "type": "DRUG" }, { "name": "ALKS 2680, 6mg", "type": "DRUG" }, { "name": "ALKS 2680, 8mg", "type": "DRUG" }, { "name": "ALKS 2680, 10mg", "type": "DRUG" }, { "name": "ALKS 2680, 14mg", "type": "DRUG" }, { "name": "ALKS 2680, 18mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 256, "start_date": "2025-01-27", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06767683" }, { "nct_id": "NCT06952699", "title": "A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 2" ], "interventions": [ { "name": "TAK-360", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 88, "start_date": "2025-05-06", "completion_date": "2026-08-20", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 12, "location_summary": "Redwood City, California • Santa Ana, California • Colorado Springs, Colorado + 9 more", "locations": [ { "city": "Redwood City", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Brandon", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06952699" }, { "nct_id": "NCT03772314", "title": "Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Idiopathic Hypersomnia", "Narcolepsy Without Cataplexy" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Amphetamine-Dextroamphetamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 44, "start_date": "2019-04-15", "completion_date": "2023-05-04", "has_results": true, "last_update_posted_date": "2024-05-23", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03772314" }, { "nct_id": "NCT05066009", "title": "Sleep/Wake State Assessment with Non-invasive Earbuds", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypersomnolence" ], "interventions": [ { "name": "NextSense EEG-enabled earbuds", "type": "DEVICE" }, { "name": "Ellcie Healthy eyeglasses", "type": "DEVICE" }, { "name": "Drug Holiday", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 8, "start_date": "2021-10-13", "completion_date": "2023-10-27", "has_results": false, "last_update_posted_date": "2025-02-11", "last_synced_at": "2026-05-22T08:10:12.673Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05066009" } ] }